{"type":"rich","url":"https://www.emjreviews.com/en-us/amj/oncology/interactive-article/fda-approves-imfinzi-plus-carboplatin-and-paclitaxel-for-certain-patients-with-endometrial-cancer/","title":"Novel Treatment Option in Endometrial Cancer","html":"<div style=\"position:relative;width:auto;padding:0 0 946.60%;height:0;top:0;left:0;bottom:0;right:0;margin:0;border:0 none\" id=\"experience-673b6953b12dd\" data-aspectRatio=\"0.10564103\" data-mobile-aspectRatio=\"0.10564103\"><iframe allowfullscreen src=\"https://view.ceros.com/european-medical-group/novel-treatment-option-in-endometrial-cancer?heightOverride=7800&mobileHeightOverride=7800\" style=\"position:absolute;top:0;left:0;bottom:0;right:0;margin:0;padding:0;border:0 none;height:1px;width:1px;min-height:100%;min-width:100%\" frameborder=\"0\" class=\"ceros-experience\" title=\"Novel Treatment Option in Endometrial Cancer\" scrolling=\"no\"></iframe></div><script type=\"text/javascript\" src=\"https://view.ceros.com/scroll-proxy.min.js\" data-ceros-origin-domains=\"view.ceros.com\"></script>","width":824,"height":7800,"provider_name":"Ceros","provider_url":"https://ceros.com","version":"1.0","embedType":"full-height"}